
QI Path is an AI-driven adaptive risk intelligence platform designed for the life sciences industry, including pharmaceutical, biotech, CROs, drug manufacturers, government agencies, and health systems. It leverages machine learning to detect hidden risks, automate analysis, and accelerate smarter decision-making to reduce errors, improve quality, and enable data-informed decisions. The platform integrates real-time AI insights with historical data and frontline feedback to proactively address risks before they become costly failures. QI Path's solution is built for compliance with regulatory standards such as ICH E6(R2/R3), Q9, and QbD, and has proven to reduce clinical and operational quality issues by over 75% across 300+ early-phase studies. It helps organizations reduce costs, prevent quality issues, ensure regulatory compliance, and drive continuous process improvement and operational excellence at scale.

QI Path is an AI-driven adaptive risk intelligence platform designed for the life sciences industry, including pharmaceutical, biotech, CROs, drug manufacturers, government agencies, and health systems. It leverages machine learning to detect hidden risks, automate analysis, and accelerate smarter decision-making to reduce errors, improve quality, and enable data-informed decisions. The platform integrates real-time AI insights with historical data and frontline feedback to proactively address risks before they become costly failures. QI Path's solution is built for compliance with regulatory standards such as ICH E6(R2/R3), Q9, and QbD, and has proven to reduce clinical and operational quality issues by over 75% across 300+ early-phase studies. It helps organizations reduce costs, prevent quality issues, ensure regulatory compliance, and drive continuous process improvement and operational excellence at scale.